openPR Logo
Press release

Deadline on August 17th coming up in Lawsuit for Investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI)

07-28-2020 08:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on August 17, 2020 in the lawsuit for certain investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI).

A Deadline is coming up on August 17, 2020 in the lawsuit for certain investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI).

The Shareholders Foundation announced that a deadline is coming up on August 17, 2020in the lawsuit filed for certain investors of Chembio Diagnostics, Inc. (NASDAQ: CEMI) over alleged securities laws violations by Chembio Diagnostics, Inc.

Investors who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) have certain options and there are strict and short deadlines running. Deadline: August 17, 2020. NASDAQ: CEMI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Chembio Diagnostics, Inc. (NASDAQ: CEMI) common shares between April 1, 2020 and June 16, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 1, 2020 and June 16, 2020 the Company failed to disclose that, the Company’s Dual Path Platform (“DPP”) COVID-19 test did not provide high-quality results and there were material performance concerns with the accuracy of the test such that it was not reasonable to believe that the test may be effective in detecting antibodies against SARS-CoV-2; and as a result, there was a material risk to public health from the false test results.

Those who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) have certain options and should contact the Shareholders Foundation.

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on August 17th coming up in Lawsuit for Investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI) here

News-ID: 2098357 • Views: 307

More Releases from Shareholders Foundation

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA. Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA
Investigation announced for Long-Term Investors in shares of Milestone Pharmaceu …
Certain directors of Milestone Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) and currently hold any of those NASDAQ: MIST shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Milestone Pharmaceuticals directors breached their fiduciary duties and caused damage to the
Investigation announced for Long-Term Investors in shares of iQIYI, Inc. (NASDAQ …
An investigation was announced for investors in shares of iQIYI, Inc. (NASDAQ: IQ) concerning potential breaches of fiduciary duties by certain directors and officers of iQIYI, Inc.. Investors who are current long term investors in iQIYI, Inc. (NASDAQ: IQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IQ
Investigation announced for Investors in shares of Noble Energy, Inc. (NASDAQ: N …
An investigation was announced concerning whether the takeover of Noble Energy, Inc.is unfair to: NBL stockholders. Investors who purchased shares of Noble Energy, Inc. (NASDAQ: NBL) and currently hold any of those NASDAQ: NBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Noble Energy, Inc. breached their fiduciary duties

All 5 Releases


More Releases for Chembio

Veterinary Rapid Diagnostic Tests Market By Top Key Players- Dutch Diagnostics B …
MarketResearchReports.Biz has recently added a research document to their roster titled "Veterinary Rapid Diagnostic Tests Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025". Veterinary rapid diagnostic test is medical diagnostic test that is quick and easy to perform. Veterinary rapid diagnostic test is more accurate than presumptive diagnosis and can be used at home. Veterinary rapid diagnostic test gives result in
Syphilis Rapid Test Kit Market is Growing Vigorously Worldwide by Top Players: A …
Syphilis Rapid Test Kit is used to detect or diagnose an infection with Treponema pallidum, the bacteria that causes syphilis. Syphilis Rapid Test Kit market report is basically an exhaustive analysis of this industry that includes information on the scope of the product, the size of the market, sales and revenues, and the vital dynamics of the market. Essentially, market dynamics here include the opportunities offered by the market for the
Zika Virus Testing Market Comprehensive Research by Including Top Companies: Che …
Description Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the
Zika Virus Testing Market Business Growth Statistics and Key Players Insights: C …
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting
Physician Office Laboratory (POL) Market : Drivers and Restraints | Accriva Diag …
The global market for physician office laboratory (POL) has been expanding substantially over the last few years. Supported by the technological advancements, the market is likely to remain proliferating over the next few years. POL testing has its base in developed regions as emerging economies still rely on hospital infrastructure for the diagnosis of acute and chronic medical conditions. Developing regions, however, has been demonstrating a significant potential for decentralized
Zika Virus Testing 2018 Global Market Key Players – Chembio, Quest Diagnostics …
WiseGuyRerports.com Presents “Global Zika Virus Testing Market Research Report 2018” New Document to its Studies Database This report studies the Zika Virus Testing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Zika Virus Testing market by product type and applications/end industries. Geographically, this report is segmented into